Issue 1/2016
Content (27 Articles)
The engagement of FDG PET/CT image quality and harmonized quantification: from competitive to complementary
Ronald Boellaard
Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients: from 223Ra-dichloride to new horizons for therapeutic response assessment
Emilio Bombardieri, L. Evangelista, G. L. Ceresoli, F. Boccardo
Factors affecting 223Ra therapy: clinical experience after 532 cycles from a single institution
Elba C. Etchebehere, Denái R. Milton, John C. Araujo, Nancy M. Swanston, Homer A. Macapinlac, Eric M. Rohren
Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting 223Ra-dichloride
Massimiliano Pacilio, Guido Ventroni, Giuseppe De Vincentis, Bartolomeo Cassano, Rosanna Pellegrini, Elisabetta Di Castro, Viviana Frantellizzi, Giulia Anna Follacchio, Tatiana Garkavaya, Leda Lorenzon, Pasquale Ialongo, Roberto Pani, Lucio Mango
68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients
Florian Sterzing, Clemens Kratochwil, Hannah Fiedler, Sonja Katayama, Gregor Habl, Klaus Kopka, Ali Afshar-Oromieh, Jürgen Debus, Uwe Haberkorn, Frederik L. Giesel
Dosimetry for 177Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer
Andreas Delker, Wolfgang Peter Fendler, Clemens Kratochwil, Anika Brunegraf, Astrid Gosewisch, Franz Josef Gildehaus, Stefan Tritschler, Christian Georg Stief, Klaus Kopka, Uwe Haberkorn, Peter Bartenstein, Guido Böning
Of standard of reference and accuracy: the problem of truth in imaging
Stefano Fanti, Elisabetta Lalumera
PET/CT with 11C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data
Stefano Fanti, Silvia Minozzi, Paolo Castellucci, Sara Balduzzi, Ken Herrmann, Bernd Joachim Krause, Wim Oyen, Arturo Chiti
Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer
Martin T. Freitag, Jan P. Radtke, Boris A. Hadaschik, A. Kopp-Schneider, Matthias Eder, Klaus Kopka, Uwe Haberkorn, Matthias Roethke, Heinz-Peter Schlemmer, Ali Afshar-Oromieh
11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel
Francesco Ceci, Paolo Castellucci, Tiziano Graziani, Riccardo Schiavina, Riccardo Renzi, Marco Borghesi, Piergiorgio Di Tullio, Eugenio Brunocilla, Andrea Ardizzoni, Stefano Fanti
Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI
Benedikt Michael Schaarschmidt, Philipp Heusch, Christian Buchbender, Marcus Ruhlmann, Christoph Bergmann, Verena Ruhlmann, Marc Schlamann, Gerald Antoch, Michael Forsting, Axel Wetter
Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [18F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience
Otto M. Henriksen, Vibeke A. Larsen, Aida Muhic, Adam E. Hansen, Henrik B. W. Larsson, Hans S. Poulsen, Ian Law
Imaging malignant melanoma with 18F-5-FPN
Hongyan Feng, Xiaotian Xia, Chongjiao Li, Yiling Song, Chunxia Qin, Qingyao Liu, Yongxue Zhang, Xiaoli Lan
Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series
C. Brendle, N. F. Schwenzer, H. Rempp, H. Schmidt, C. Pfannenberg, C. la Fougère, K. Nikolaou, C. Schraml
Textural analysis of pre-therapeutic [18F]-FET-PET and its correlation with tumor grade and patient survival in high-grade gliomas
Thomas Pyka, Jens Gempt, Daniela Hiob, Florian Ringel, Jürgen Schlegel, Stefanie Bette, Hans-Jürgen Wester, Bernhard Meyer, Stefan Förster
Amyloid imaging in cognitively normal older adults: comparison between 18F-flutemetamol and 11C-Pittsburgh compound B
Katarzyna Adamczuk, Jolien Schaeverbeke, Natalie Nelissen, Veerle Neyens, Mathieu Vandenbulcke, Karolien Goffin, Johan Lilja, Kelly Hilven, Patrick Dupont, Koen Van Laere, Rik Vandenberghe
Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [11C]ABP688 PET
Jonathan M. DuBois, Olivier G. Rousset, Jared Rowley, Manuel Porras-Betancourt, Andrew J. Reader, Aurelie Labbe, Gassan Massarweh, Jean-Paul Soucy, Pedro Rosa-Neto, Eliane Kobayashi
Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [18F]DPA-714 PET
Dieter Ory, Andrey Postnov, Michel Koole, Sofie Celen, Bart de Laat, Alfons Verbruggen, Koen Van Laere, Guy Bormans, Cindy Casteels
Test–retest reproducibility of [11C]PBR28 binding to TSPO in healthy control subjects
K. Collste, A. Forsberg, A. Varrone, N. Amini, S. Aeinehband, I. Yakushev, C. Halldin, L. Farde, S. Cervenka
Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease
Soichiro Shimizu, Kentaro Hirao, Hidekazu Kanetaka, Nayuta Namioka, Hirokuni Hatanaka, Daisuke Hirose, Raita Fukasawa, Takahiko Umahara, Hirohumi Sakurai, Haruo Hanyu
Intense PSMA-expression using 68Ga-PSMA PET/CT in a paravertebral schwannoma mimicking prostate cancer metastasis
Christoph Rischpler, Tobias Maurer, Markus Schwaiger, Matthias Eiber
Paget bone disease demonstrated on 68Ga-PSMA ligand PET/CT
C. Artigas, J. Alexiou, C. Garcia, Z. Wimana, F-X. Otte, T. Gil, R. Van Velthoven, P. Flamen
Patient’s weight: a neglected cause of variability in SUV measurements? A survey from an EARL accredited PET centre in 513 patients
Charline Lasnon, Benjamin Houdu, Emmanuel Kammerer, Thibault Salomon, Jeremy Devreese, Adrien Lebasnier, Nicolas Aide
Prostate-specific antigen and radiolabelled choline PET/CT for the assessment of response to therapy: synergy or conflicting?
Laura Evangelista, Emilio Bombardieri
Erratum to: Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting
Daniela Perani, Chiara Cerami, Silvia Paola Caminiti, Roberto Santangelo, Elisabetta Coppi, Laura Ferrari, Patrizia Pinto, Gabriella Passerini, Andrea Falini, Sandro Iannaccone, Stefano Francesco Cappa, Giancarlo Comi, Luigi Gianolli, Giuseppe Magnani
Erratum to: Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis
Georg Kuhnert, Ronald Boellaard, Sergej Sterzer, Deniz Kahraman, Matthias Scheffler, Jürgen Wolf, Markus Dietlein, Alexander Drzezga, Carsten Kobe
Erratum to: Difficulties in deciding whether to ablate patients with putatively “low–intermediate-risk” differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance study
Savvas Frangos, Ioannis P. Iakovou, Robert J. Marlowe, Nicolaos Eftychiou, Loukia Patsali, Anna Vanezi, Androulla Savva, Vassilis Mpalaris, Evanthia I. Giannoula